Horizons Fall 2015

8 NSU HORIZONS New Leaders NSU CONTINUES TO ATTRACT EXPERTS IN THEIR FIELDS. H. Thomas Temple, M.D., is now the senior vice presi- dent of translational research and economic development , a new position created to support NSU’s faculty members in developing their innovative ideas, discov- eries, and technologies. In this role, Temple is respon- sible for building the connec- tions, resources, and entrepreneurial energy for the commercialization of NSU’s research activities. Temple will be establishing partnerships with companies, investors, and entrepreneurs interested in using NSU’s vast wet and dry lab space in the Center for Collaborative Research (CCR) to conduct research and develop technologies benefitting the global community. The 215,000-square-foot, $80-million CCR is slated to open in the spring of 2016. Additionally, he will be leveraging the resources of the CCR to further support the cutting-edge research conducted at NSU’s Halmos College of Natural Sciences and Oceanography. Temple’s position represents a partnership with Hospital Corporation of America (HCA) East Florida hospitals, where he has been granted privileges and will maintain a surgical practice complementing his role with NSU. “As we near completion of the CCR, we begin to take the necessary steps to add a teaching and research hospital on campus. It is essential that we focus on building strategic business and research partnerships leading to the creation of new patents, licenses, and business start-ups as well as the expansion of existing companies as we have envisioned,” said George L. Hanbury II, Ph.D., president and CEO of Nova Southeastern University. Toward that effort, the CCR will be a leading technology incuba- tor that will house NSU’s General Clinical Research Center, an outpatient facility providing a centralized clinical research infrastructure to benefit investigators in multiple disciplines. These include NSU’s Institute for Neuro-Immune Medicine; Rumbaugh-Goodwin Institute for Cancer Research; Emil Buehler Research Center for Engineering, Science, and Mathematics; and the U.S. Geological Survey. It is estimated that these combined efforts will add $500 million to NSU’s current $2.6-billion economic impact on the state of Florida. Temple brings to NSU his long-established reputation as a successful surgeon, researcher, and leader spanning nearly three decades. He joined NSU from the University of Miami Miller School of Medicine, where he served as chief of the Orthopaedic Oncology Division, director of the University of Miami Tissue Bank, professor of orthopaedic and pathology, and vice-chairman of the Department of Orthopaedics. Temple’s clinical interests include a novel treatment of benign and malignant bone and soft tissue tumors in children and adults, tissue transplantation, and complex limb reconstruction. His research interests are stem-cell applications in bone and cartilage regeneration, tissue banking, and developing targeted therapies for sarcomas. Temple earned his Bachelor of Arts degree from Harvard University and his Doctor of Medicine from Jefferson Medical College in Philadelphia. He completed his residency in orthopedic surgery at Walter Reed Army Medical Center in Washington, D.C., and his musculoskeletal oncology fellowship at Harvard University/Massachusetts General Hospital/Boston Children’s Hospital in Boston. He is board certified by the American Board of Orthopaedic Surgery. H. THOMAS TEMPLE